Generel mortalitet og mortalitet uden recidiv mere end 100 dage efter transplantationen var henholdsvis (8/ 61) 13% og (6/ 61) 10% hos allotransplanterede patienter.
Overall mortality and non- relapse mortality at more than 100 days post-transplant was (8/ 61) 13% and (6/ 61) 10% in allotransplanted patients, respectively.